The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InGE HealthCare has announced the expansion of its strategic collaboration with DeepHealth, a subsidiary of RadNet, to deploy AI-powered breast cancer screening solutions globally. The partnership integrates advanced diagnostic applications, including ProFound Pro and Safeguard Review, into GE HealthCare’s mammography portfolio. This initiative aims to enhance early detection precision and significantly improve clinical workflow efficiency for healthcare providers. By broadening the international availability of the DeepHealth AI Breast Suite, both companies seek to advance women's health through better diagnostic outcomes. This move strengthens GE HealthCare's competitive edge in the rapidly growing healthcare AI market. Furthermore, the agreement provides RadNet’s subsidiary with a massive global distribution channel through GE’s established network.